GOOD HOPE HOSPITAL INC
1. Target Overview & Investment Thesis
GOOD HOPE HOSPITAL INC is a 16-bed under-performing / distressed in HARNETT, NC with $2.3M in net patient revenue and a -62.6% operating margin. The hospital serves a payer mix of 5.8% Medicare, 19.3% Medicaid, and 74.9% commercial.
Thesis: Turnaround. Our ML models identify $184K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -62.6% to -54.5% (+802bps).
| Net Revenue HCRIS | $2.3M |
| Current EBITDA COMPUTED | $-1.4M |
| Operating Margin COMPUTED | -62.6% |
| Occupancy HCRIS | 76.5% |
| Revenue / Bed COMPUTED | $143K |
| Net-to-Gross HCRIS | 100.0% |
| Distress Probability ML | 53.9% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -62.6% places it below the state median. Among 25 size-comparable peers (8-32 beds), the median margin is -6.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (8-32), prioritizing same-state peers. 25 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GOOD HOPE HOSPITAL INC (Target) | NC | 16 | $2.3M | -62.6% |
| THE OUTER BANKS HOSPITAL | NC | 21 | $93.7M | 26.2% |
| MEDICAL PARK HOSPITAL | NC | 22 | $82.6M | 15.8% |
| NORTH CAROLINA SPECIALTY HOSPI | NC | 18 | $71.6M | 11.7% |
| THE MCDOWELL HOSPITAL | NC | 30 | $65.7M | -6.7% |
| CHOWAN HOSPITAL INC. | NC | 25 | $61.5M | 10.4% |
| MURPHY MEDICAL CENTER | NC | 25 | $58.0M | -8.8% |
| J ARTHUR DOSHER MEMORIAL HOSPI | NC | 25 | $57.6M | 3.8% |
| ST LUKES HOSPITAL | NC | 25 | $50.4M | -1.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $184K (802bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Denial Rate Reduction | 12.0% | 6.5% | $52K | +229bp | 12mo |
| Net Collection Rate | 93.5% | 97.0% | $48K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $46K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $28K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +42bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-1.4M |
| + RCM Uplift | +$184K |
| Pro Forma EBITDA | $-1.2M |
| Current Margin | -62.6% |
| Pro Forma Margin | -54.5% |
| WC Released (1x) | $88K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-2.2M | $-7.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-2.2M | $-9.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-2.0M | $-9.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-2.0M | $-10.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-2.4M | $-7.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-2.4M | $-9.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 53.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 25 hospitals with 8-32 beds
- Same-state prioritization (n=26)
- Comp margins: P25=-16.3% / P50=-6.7% / P75=3.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.